SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Y. Maxine Miller who wrote (356)2/24/1997 10:02:00 PM
From: Larry Liebman   of 6136
 
Actually, the volatility might be somewhat less than when it traded <$60...Merck, with a billion+ shares has cruised up and down with 2-3 point gains and losses...It is hardly surprising that AGPH with 13 million shares out can remind one of the Cyclone at Coney Island...A question of followers of AGPH...I was of the understanding that there was an F.D.A. meeting on 2/21...Was that not the case?...I've been wondering if anxiety is setting in regarding the approval of Viracept, as more than the legendary 42 days of approval for a PI may has vanished...I called the company last week and they were talking of filing for approval of THYMITAQ in '98...While all eyes are on Viracept, the pipeline has been pushed into the background...At some point news of the MMP will begin to "intrigue" the market....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News